Drawing for LUMI

USPTO serial 87096016

LUMI

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CHADAB, SETH WILLIG
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LUMI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jonathan A. Hyman

JONATHAN A. HYMAN KNOBBE MARTENS OLSON & BEAR LLP2040 MAIN ST., FL 14IRVINE, CA 92614UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Surgical and medical apparatus, instruments and devices for embolization; medical apparatus and instruments for embolisation; embolic devices for treating arteriovenous malformations (AVMs) of the body; embolic devices for use in treating tumors; medical devices in the nature of particles, namely, embolic microspheres for embolisation; medical devices in the nature of embolic particles for use in vascular embolisation; drug delivery embolisation apparatus and instruments for treatment of circulatory system conditions and for the treatment of tumors and AVMs; drug delivery embolisation apparatus, instruments and systems; surgical and medical apparatus and instruments for treatment of circulatory system conditions and for the treatment of tumors and AVMs; component and replacement parts for all the aforesaid goodsACTIVE—
041Education services, namely, conducting online and telephonic instruction and courses in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content for apps (applications) for mobile devices and computers, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information; providing computer, electronic and online databases for education and medical purposes in the field of healthcare, medicine, medical treatment and patient care; training in the use and operation of medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the fields of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; educational services, namely, providing non-downloadable webinars in the field of health and medical information and distribution of course material in connection therewith; education services, namely, developing, arranging and conducting educational conferences and programmes and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; Providing training programs and developing training programs relating to the use and operation of medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; Providing online publications, namely, teaching guides, instructional materials, brochures, and course books, in the field of pharmaceutical products, healthcare and medical disease, disorders and related treatments; conducting educational seminars in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science and medicineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 5, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 5, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 11, 2020DOCKASSIGNED TO EXAMINER—
Oct 3, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 2, 2019EX5GSOU EXTENSION 5 GRANTED—
Oct 2, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 27, 2019EXT5SOU EXTENSION 5 FILED—
Sep 27, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 27, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 25, 2019EX4GSOU EXTENSION 4 GRANTED—
Mar 25, 2019EXT4SOU EXTENSION 4 FILED—
Mar 25, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 20, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 18, 2018EX3GSOU EXTENSION 3 GRANTED—
Sep 18, 2018EXT3SOU EXTENSION 3 FILED—
Sep 18, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 28, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 26, 2018EX2GSOU EXTENSION 2 GRANTED—
Mar 26, 2018EXT2SOU EXTENSION 2 FILED—
Mar 26, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 3, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 29, 2017EX1GSOU EXTENSION 1 GRANTED—
Sep 29, 2017EXT1SOU EXTENSION 1 FILED—
Sep 29, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 4, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 7, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 7, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 18, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 3, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 12, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 10, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 10, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 7, 2016ALIEASSIGNED TO LIE—
Nov 18, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 8, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 8, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 8, 2016DOCKASSIGNED TO EXAMINER—
Jul 12, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 11, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance